metricas
Clínica e Investigación en Arteriosclerosis Vascular age calculation from SCORE2 and SCORE2-OP cardiovascular risk tables
Información de la revista
Vol. 38. Núm. 3.
(Mayo - Junio 2026)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Vol. 38. Núm. 3.
(Mayo - Junio 2026)
Original article

Vascular age calculation from SCORE2 and SCORE2-OP cardiovascular risk tables

Visitas
1114
Jose I. Cuendea,
Autor para correspondencia
jcuendem@gmail.com

Corresponding author.
, Carlos Guijarrob
a Department of Medicine, Dermatology and Toxicology, University of Valladolid, Spain
b Department of Internal Medicine, Hospital Universitario Fundación Alcorcón-Universidad Rey Juan Carlos, Alcorcon, Madrid. Spain
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Abstract
Aims

SCORE2 and SCORE2-OP cardiovascular risk tables were published in 2021 and incorporated into European cardiovascular prevention guidelines, replacing the previous SCORE tables. Since the 2012 version of these guidelines, the concept of vascular age has been included. Although there are vascular age tables derived from SCORE, there are no vascular age tables derived from SCORE2 and SCORE2-OP. The aim of this study is to construct new vascular age tables derived from SCORE2 and SCORE2-OP.

Methods

Based on the data from the SCORE2 and SCORE2-OP risk tables, 8 regressions between age and risk are calculated in baseline conditions for the 8 combinations of sex and cardiovascular risk zones. Another 248 regressions corresponding to the different non-baseline situations are calculated. By equating the risk in each box of the risk tables with the same risk in baseline conditions, the vascular age in each box of the risk tables can be obtained. Regression, determination and intraclass correlation coefficients are calculated to asses adjustment and agreement.

Results

Four vascular age tables have been obtained corresponding to countries with low, moderate, high and very high cardiovascular risk. The concordance in vascular age between the 4 tables is greater than 0.99, thus a universal vascular age table has been constructed. Vascular age does not need calibration unlike absolute risk.

Conclusions

Vascular age tables have been created from the SCORE2 and SCORE2-OP tables. A single vascular age table may be used for all European Countries.

Keywords:
Vascular age
SCORE2
Agreement

Artículo

Opciones para acceder a los textos completos de la publicación Clínica e Investigación en Arteriosclerosis
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
References
[1]
R.M. Conroy, K. Pyorala, A.P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, et al.
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
Eur Heart J, 24 (2003), pp. 987-1003
[2]
G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, J. Dallongeville, et al.
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
Eur J Cardiovasc Prev Rehabil, 10 (2003), pp. S1-S10
[3]
European Association for Cardiovascular Prevention & Rehabilitation, Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, et al.
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Eur Heart J, 32 (2011), pp. 1769-1818
[4]
K.M. Anderson, P.W. Wilson, P.M. Odell, W.B. Kannel.
An updated coronary risk profile.
Circulation, 83 (1991), pp. 356-362
[5]
J.I. Cuende, N. Cuende, J. Calaveras-Lagartos.
How to calculate vascular age with the SCORE project scales: a new method of cardiovascular risk evaluation.
Eur Heart J, 31 (2010), pp. 2351-2358
[6]
F.L.J. Visseren, F. Mach, Y.M. Smulders, D. Carballo, K.C. Koskinas, M. Bäck, et al.
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Eur J Prev Cardiol, 29 (2022), pp. 5-115
[7]
F. Mach, C. Baigent, A.L. Catapano, K.C. Koskinas, M. Casula, L. Badimon, et al.
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
Eur Heart J, 41 (2020), pp. 111-188
[8]
SCORE2 working group and ESC Cardiovascular risk collaboration.
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
Eur Heart J, 42 (2021), pp. 2439-2454
[9]
SCORE2-OP working group and ESC Cardiovascular risk collaboration.
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
Eur Heart J, 42 (2021), pp. 2455-2467
[10]
A.A. Lopez-Gonzalez, A. Aguilo, M. Frontera, M. Bennasar-Veny, I. Campos, T. Vicente-Herrero, et al.
Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial.
Eur J Prev Cardiol, 22 (2015), pp. 389-396
[11]
J. Cuende, A. Alba, C. Ferrer, J. Pardo, F. Sanchez barranco, I. Perez de Diego.
Vascular risk age from Framingham heart study does not need to be calibrated.
Rev Clin Esp, 212 (2012), pp. 431-432
asdasdasd
Opciones de artículo
Herramientas
Material suplementario